Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02547857
Other study ID # HSR 14-3918
Secondary ID
Status Completed
Phase N/A
First received June 15, 2015
Last updated December 23, 2016
Start date September 2015

Study information

Verified date December 2016
Source Minneapolis Medical Research Foundation
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

Pelvic ultrasound is frequently performed in the ED in non-pregnant women to assess for ovarian pathology, though its use has not been described in the medical literature. This observational study aims to describe its use in clinical ED practice.


Description:

Pelvic ultrasound is frequently performed in the ED in non-pregnant women to assess for ovarian pathology. During the pelvic examination a transvaginal ultrasound probe is used to visualize ovarian size, determine echotexture, assess whether ovarian tenderness is present, and sometimes measure ovarian blood flow. Though pelvic ultrasound is used in the Hennepin County Medical Center ED routinely, there is a paucity of literature assessing it's utility.

This observational study will help determine the usefulness of this imaging modality, and how often it changes management in clinical practice.

Specifically, this study will attempt to determine how often transvaginal ultrasound identifies the structures of interest, and then will correlate these findings with the final ED diagnosis. If a formal ultrasound is obtained, the findings of the ED ultrasound will also be compared to the findings of the formal ultrasound.

The treating physicians will be queried the diagnosis and management plans before and after the pelvic US to ascertain changes in management.


Recruitment information / eligibility

Status Completed
Enrollment 114
Est. completion date
Est. primary completion date October 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age >= 18 years old female

- ED bedside transvaginal ultrasound to be performed in a non-pregnant woman with at least one ovary

- Willing to discuss how they are doing at 7-10 days via phone

- Valid phone number

Exclusion Criteria:

- If a diagnosis of ovarian torsion, mass, TOA or other ovarian pathology is known before ED ultrasound

- Previously enrolled in this study

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Pelvic US
To be eligible for inclusion, a woman will have pelvic US completed as part of her ED stay. This is a non-interventional study.

Locations

Country Name City State
United States Hennepin County Medical Center Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Minneapolis Medical Research Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Method of finding ovaries Will choose from:
Adjacent to pelvic vessels
Followed out from uterine cornu
No particular method used
8 hours (or less, this will measure what occurs during an ED stay) No
Other Experience of sonographer Choose from:
G1
G2
G3-G5
Physician Assistant (PA)
Attending
US tech
8 hours (or less, this will measure what occurs during an ED stay) No
Other Pelvic physical exam characteristics Was there tenderness on the exam (right/left adnexa, suprapubic region, no tenderness)? Were any masses felt? (right/left adnexa, suprapubic, no mass) 8 hours (or less, this will measure what occurs during an ED stay) No
Primary Change in diagnosis before/after pelvic US The treating physician will be queried the likelihood of EMERGENT and NON-EMERGENT ovarian pathology before and after pelvic US using the following scale: Definite, Probable, Possible, Very Unlikely. The ED tests reviewed before each of these judgements will be noted. EMERGENT is defined as ovarian torsion or tubo-ovarian abscess (TOA). NON-EMERGENT is defined as all other causes, including ovarian cyst, ovarian mass, ovarian malignancy, adnexal mass). The clinician will also free text the most likely diagnosis. A change of two or more levels (eg definite to possible, definite to very unlikely, probable to very unlikely, or vice versa) will be assumed to be a significant change in diagnosis. 8 hours (or less, this will measure what occurs during an ED stay) No
Primary Change in management plan before/after pelvic US The treating physician will choose from the following regarding the management plan before/after the pelvic US: outpatient referral to OB/GYN, formal pelvic US after bedside US, consult GYN in the ED, urgent/emergent operative intervention, None of the above. Any difference in management before/after pelvic US will be considered a significant change in management. 8 hours (or less, this will measure what occurs during an ED stay) No
Secondary Sonographic visualization of ovaries yes/no 8 hours (or less, this will measure what occurs during an ED stay) No
Secondary Duration of pelvic US Less than 5 minutes, 5-10 minutes, more than 10 minutes 8 hours (or less, this will measure what occurs during an ED stay) No
Secondary Ovary enlargement Were the ovaries larger than 3.5 x 2 cm in any plane? yes/no answer 8 hours (or less, this will measure what occurs during an ED stay) No
Secondary Ovarian tenderness, sonographic As a dichotomous yes/no. This will be correlated to final diagnosis. How many women with a non-tender ovary ended up with EMERGENT pathology? How many had NON-EMERGENT pathology? 8 hours (or less, this will measure what occurs during an ED stay) No
Secondary Ovarian blood flow The physician will determine if the ovarian flow is normal in a dichotomous yes/no answer. (if performed) 8 hours (or less, this will measure what occurs during an ED stay) No
Secondary ED disposition after visit This will measure if the patient is discharged from the ED or admitted to the hospital 8 hours (or less, this will measure what occurs during an ED stay) No
Secondary Final ED diagnosis Two questions will be answered:
Ovarian Pathology, Emergency (tubo-ovarian abscess, torsion)
Ovarian Pathology, Non-Emergency (cyst, mass, malignancy)
Non-ovarian problem
Question 2:
Final ED diagnosis after all work-up: (select all that apply) checkbox
ed_final_dx_2___1 ovarian cyst
ed_final_dx_2___2 ovarian mass
ed_final_dx_2___3 ovarian torsion
ed_final_dx_2___4 tubo-ovarian abscess
ed_final_dx_2___5 other ovarian pathology
ed_final_dx_2___6 adnexal mass (non-ovarian)
ed_final_dx_2___7 Pelvic Inflammatory Disease
ed_final_dx_2___8 Abdominal pathology (appendicitis, diverticulitis, SBO, others)
ed_final_dx_2___9 Non-specific abdominal pain
ed_final_dx_2___10 None of the above and no ovarian pathology suspected
8 hours (or less, this will measure what occurs during an ED stay) No
Secondary 7-day follow-up Whether another facility was visited, whether a procedure occurred, and what else happened during this stay. Patients will be attempted to be contacted three times. 7 days No
Secondary Correlation between ED US and Formal US If a formal US is obtained, the reading will be abstracted and compared to the ED US for the following: ovary visualization, ovary size, ovarian flow, final diagnosis, and any other abnormality in free text. 8 hours (or less, this will measure what occurs during an ED stay) Yes
Secondary Final impression for ED ultrasound with regards to ovaries NORMAL or ABNORMAL. If abnormal, the abnormality will be described. 8 hours (or less, this will measure what occurs during an ED stay) No
Secondary Formal pelvic US Was this study obtained? dichotomous yes/no. And why was a formal pelvic US obtained? (abnormality of ovaries on bedside US; other abnormality on bedside US; unable to visualize ovaries on bedside US; good visualization of all structures and all structures normal, but post-test probability still high; Other (free text). )The exact reason will then be listed in free text. 8 hours (or less, this will measure what occurs during an ED stay) No
See also
  Status Clinical Trial Phase
Completed NCT04682860 - Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide Phase 4
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Completed NCT03318614 - Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster Phase 2/Phase 3
Completed NCT02923245 - POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound N/A
Completed NCT02676232 - DARWeb: an Online Psychosocial Intervention for Children With Recurrent Abdominal Pain and Their Families. N/A
Completed NCT02197780 - Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD N/A
Recruiting NCT00209807 - Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder Phase 4
Terminated NCT01410071 - Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction N/A
Terminated NCT01736280 - Evaluating and Treating Potential Research Participants With Digestive Disorders N/A
Enrolling by invitation NCT04104867 - Effectiveness of Prokinetic Agents in Improving Abdominal Discomfort at Colonoscopy N/A
Completed NCT03574727 - Abdominal Cutaneous Nerve Entrapment Syndrome
Completed NCT04614649 - Right Iliac Fossa Treatment-Turkey Audit
Completed NCT05438654 - Improvement of Diagnostic Approach Using PoCUS for Right Upper Quadrant Abdominal Pain N/A
Completed NCT03558009 - Epidemiological Analysis for Hereditary Angioedema Disease
Terminated NCT03148288 - Vitamin D Supplementation in IBS N/A
Completed NCT03708874 - Pain Management of Emergency Laparoscopic Cholecystectomy in Patients With Acute Cholecystitis
Withdrawn NCT04408872 - EUS vs EGD in Emergency Room Patients Referred for EGD N/A
Recruiting NCT02594774 - Efficacy of Osteopathic Treatment in Function Abdominal Pain in Children and Adolescents N/A
Recruiting NCT02105090 - Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy Phase 4
Recruiting NCT01587846 - Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children Phase 3